KR100768961B1 - α' 클로로케톤의 제조방법 - Google Patents
α' 클로로케톤의 제조방법 Download PDFInfo
- Publication number
- KR100768961B1 KR100768961B1 KR1020037002215A KR20037002215A KR100768961B1 KR 100768961 B1 KR100768961 B1 KR 100768961B1 KR 1020037002215 A KR1020037002215 A KR 1020037002215A KR 20037002215 A KR20037002215 A KR 20037002215A KR 100768961 B1 KR100768961 B1 KR 100768961B1
- Authority
- KR
- South Korea
- Prior art keywords
- substituted
- group
- alkyl
- aryl
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title description 7
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical class ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 9
- 239000003835 ketolide antibiotic agent Substances 0.000 claims abstract description 8
- 150000007524 organic acids Chemical class 0.000 claims abstract description 8
- 125000001769 aryl amino group Chemical group 0.000 claims abstract description 5
- -1 trifluoromethoxy, hydroxy Chemical group 0.000 claims description 35
- 125000000217 alkyl group Chemical group 0.000 claims description 29
- 125000003118 aryl group Chemical group 0.000 claims description 22
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 125000001424 substituent group Chemical group 0.000 claims description 16
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 15
- 125000003107 substituted aryl group Chemical group 0.000 claims description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 14
- 125000003545 alkoxy group Chemical group 0.000 claims description 13
- 125000003277 amino group Chemical group 0.000 claims description 10
- 125000001475 halogen functional group Chemical group 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
- 125000004423 acyloxy group Chemical group 0.000 claims description 8
- 125000001691 aryl alkyl amino group Chemical group 0.000 claims description 8
- 125000004104 aryloxy group Chemical group 0.000 claims description 8
- 125000001589 carboacyl group Chemical group 0.000 claims description 8
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 8
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims description 8
- 125000004476 heterocycloamino group Chemical group 0.000 claims description 8
- 125000004470 heterocyclooxy group Chemical group 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 8
- 125000006239 protecting group Chemical group 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical group [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 5
- 125000003282 alkyl amino group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 150000007860 aryl ester derivatives Chemical class 0.000 claims description 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 4
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims description 4
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 4
- 125000005366 cycloalkylthio group Chemical group 0.000 claims description 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 4
- 125000004043 oxo group Chemical group O=* 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 3
- ZRLVQFQTCMUIRM-UHFFFAOYSA-N potassium;2-methylbutan-2-olate Chemical group [K+].CCC(C)(C)[O-] ZRLVQFQTCMUIRM-UHFFFAOYSA-N 0.000 claims description 3
- 150000004820 halides Chemical class 0.000 claims description 2
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 3
- 239000004593 Epoxy Substances 0.000 claims 2
- 150000002440 hydroxy compounds Chemical class 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 abstract description 9
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 3
- 150000002148 esters Chemical class 0.000 abstract description 3
- 239000011593 sulfur Substances 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 8
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000007858 starting material Substances 0.000 description 5
- 108010010369 HIV Protease Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 108090000783 Renin Proteins 0.000 description 3
- 102100028255 Renin Human genes 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 101710185050 Angiotensin-converting enzyme Proteins 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ABOLLEOZIFBSCW-UHFFFAOYSA-N [I+].C[S+](C)C Chemical compound [I+].C[S+](C)C ABOLLEOZIFBSCW-UHFFFAOYSA-N 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004030 hiv protease inhibitor Substances 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 239000013557 residual solvent Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 2
- ZYJPUMXJBDHSIF-NSHDSACASA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZYJPUMXJBDHSIF-NSHDSACASA-N 0.000 description 1
- 0 *CC(C1OC1)N Chemical compound *CC(C1OC1)N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 206010038997 Retroviral infections Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- RYPFDEIVUZVDCE-UHFFFAOYSA-N chloro(diiodo)methane Chemical compound ClC(I)I RYPFDEIVUZVDCE-UHFFFAOYSA-N 0.000 description 1
- PJGJQVRXEUVAFT-UHFFFAOYSA-N chloroiodomethane Chemical compound ClCI PJGJQVRXEUVAFT-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- DKWOHBPRFZIUQL-UHFFFAOYSA-N dimethyl-methylidene-oxo-$l^{6}-sulfane Chemical compound C[S+](C)([CH2-])=O DKWOHBPRFZIUQL-UHFFFAOYSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011905 homologation Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical class [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- NRZWQKGABZFFKE-UHFFFAOYSA-N trimethylsulfonium Chemical compound C[S+](C)C NRZWQKGABZFFKE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Fats And Perfumes (AREA)
- Detergent Compositions (AREA)
- Epoxy Compounds (AREA)
- Developing Agents For Electrophotography (AREA)
- Photoreceptors In Electrophotography (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (20)
- 아래의 화학식 2로 표현되는 아릴 에스테르를[화학식 2]아래의 화학식 3으로 표현되는 작용기를 갖는 화합물과 반응시켜,[화학식 3]아래의 화학식 4로 표현되는 중간체 케토 일리드 화합물을 생성시키는 것과[화학식 4]상기 화학식 4로 표현되는 화합물을 클로라이드 공급원 및 유기산으로 처리하는 것을 포함하는,아래의 화학식 1로 표현되는 α-N-아실-α'-클로로케톤의 제조 방법:[화학식 1]상기 화학식 중, R은 알킬, 치환된 알킬, 아릴 및 치환된 아릴로 구성된 군에서 선택되고, R1은 아미노기를 위한 보호기이며, R2는 수소 또는 니트로기로서, 페닐 고리의 오르토 또는 파라 위치에 치환될 수 있으며, R3과 R4는 알킬, 치환된 알킬 및 아릴로 구성된 군에서 선택되는 것인데,상기 치환된 알킬은 할로, 트리플루오로메틸, 트리플루오로메톡시, 히드록시, 알콕시, 시클로알킬옥시, 헤테로시클로옥시, 옥소, 알칸노일, 아릴, 아릴옥시, 아르알킬, 알카노일옥시, 아미노, 알킬아미노, 아릴아미노, 아르알킬아미노, 시클로알킬아미노, 헤테로시클로아미노 및 디치환 아미노로 구성된 군에서 선택되는 1 내지 4개의 치환기로 치환된 알킬기를 나타내는 것이고,상기 치환된 아릴은 알킬, 치환된 알킬, 할로, 트리플루오로메틸, 트리플루오로메톡시, 히드록시, 알콕시, 시클로알킬옥시, 헤테로시클로옥시, 알카노일, 알카노일옥시, 아미노, 알킬아미노, 디알킬아미노, 아르알킬아미노, 시클로알킬아미노, 헤테로시클로아미노, 알카노일아미노, 티올, 알킬티오, 시클로알킬티오, 헤테로시클로티오, 우레이도(ureido), 니트로, 시아노, 카르복시, 카르복시알킬, 카바밀, 알콕시카르보닐, 알킬티오노, 아릴티오노, 알킬설포닐, 설폰아미도 및 아릴옥시로 구성된 군에서 선택되는 1 내지 4개의 치환기로 치환된 아릴기를 나타내는 것으로서, 상기 치환된 아릴기의 치환기는 추가로 할로, 히드록시, 알킬, 알콕시, 아릴, 치환된 알킬, 치환된 아릴 및 아르알킬로 구성된 군에서 선택되는 1개 이상의 치환기로 치환될 수 있는 것이다.
- 제 1 항에 있어서, R이 페닐이고, R1이 t-부톡시카르보닐인 방법.
- 제 1 항에 있어서, R2가 페닐 고리의 파라 위치에 치환된 니트로인 방법.
- 제 1 항에 있어서, R3과 R4가 각각 메틸인 방법.
- 제 1 항에 있어서, 추가적으로 설폭소늄 화합물을 유기 용매 내에서 염기와 반응시켜 상기 설퍼 일리드 화합물을 생성시키는 단계를 추가적으로 포함하는 방법.
- 제 5 항에 있어서, 상기 설폭소늄 화합물이 트리알킬 설폭소늄 할라이드이고, 상기 염기가 포타슘 t--아밀레이트인 방법.
- 제 1 항에 있어서, 화학식 2로 표현되는 상기 화합물과 설퍼 일리드 화합물의 반응이 유기 용매 내에서 60℃ 내지 80℃의 온도에서 수행되는 방법.
- 제 6 항에 있어서, 상기 용매가 디메틸포름아미드, 테트라하이드로퓨란 및 톨루엔으로 구성된 군에서 선택되는 하나 이상의 용매인 방법.
- 제 1 항에 있어서, 상기 클로라이드의 공급원이 리튬 클로라이드인 방법.
- 제 1 항에 있어서, 상기 유기산이 메탄설폰산인 방법.
- 제 1 항에 있어서, 상기 화학식 4로 표현되는 케토 일리드 화합물과 클로라이드 공급원 및 유기산의 반응이 유기 용매 내에서 0℃ 내지 5℃의 온도에서 개시되는 방법.
- 제 11 항에 있어서, 상기 용매가 테트라하이드로퓨란인 방법.
- 아래의 화학식 2로 표현되는 아릴 에스테르를[화학식 2]아래의 화학식 3으로 표현되는 작용기를 갖는 화합물과 반응시켜,[화학식 3]아래의 화학식 4로 표현되는 중간체 케토 일리드 화합물을 생성시키는 것,[화학식 4]상기 화학식 4로 표현되는 화합물을 클로라이드 공급원 및 유기산으로 처리하여 아래의 화학식 1로 표현되는 1-치환-2-아미노-3-옥소-4-클로로부탄 화합물을 생성시키는 것,[화학식 1]상기 화학식 1 화합물을 환원시켜 아래의 화학식 5로 표현되는 1-클로로-2-히드록시-3-아미노-4-치환 부탄 화합물을 생성시키는 것, 및[화학식 5]상기 히드록시 화합물을 염기와 반응시켜 화학식 6으로 표현되는 에폭시 화합물을 생성시키는 것을 포함하는,아래의 화학식 6으로 표현되는 에폭시 화합물의 제조방법:[화학식 6]식 중, R은 알킬, 치환된 알킬, 아릴 및 치환된 아릴로 구성된 군에서 선택되고, R1은 아미노기를 위한 보호기이며, R2는 수소 또는 니트로기로서, 페닐 고리의 오르토 또는 파라 위치에 치환될 수 있으며, R3과 R4는 알킬, 치환된 알킬 및 아릴로 구성된 군에서 선택되는 것인데,상기 치환된 알킬은 할로, 트리플루오로메틸, 트리플루오로메톡시, 히드록시, 알콕시, 시클로알킬옥시, 헤테로시클로옥시, 옥소, 알칸노일, 아릴, 아릴옥시, 아르알킬, 알카노일옥시, 아미노, 알킬아미노, 아릴아미노, 아르알킬아미노, 시클로알킬아미노, 헤테로시클로아미노 및 디치환 아미노로 구성된 군에서 선택되는 1 내지 4개의 치환기로 치환된 알킬기를 나타내는 것이고,상기 치환된 아릴은 알킬, 치환된 알킬, 할로, 트리플루오로메틸, 트리플루오로메톡시, 히드록시, 알콕시, 시클로알킬옥시, 헤테로시클로옥시, 알카노일, 알카노일옥시, 아미노, 알킬아미노, 디알킬아미노, 아르알킬아미노, 시클로알킬아미노, 헤테로시클로아미노, 알카노일아미노, 티올, 알킬티오, 시클로알킬티오, 헤테로시클로티오, 우레이도(ureido), 니트로, 시아노, 카르복시, 카르복시알킬, 카바밀, 알콕시카르보닐, 알킬티오노, 아릴티오노, 알킬설포닐, 설폰아미도 및 아릴옥시로 구성된 군에서 선택되는 1 내지 4개의 치환기로 치환된 아릴기를 나타내는 것으로서, 상기 치환된 아릴기의 치환기는 추가로 할로, 히드록시, 알킬, 알콕시, 아릴, 치환된 알킬, 치환된 아릴 및 아르알킬로 구성된 군에서 선택되는 1개 이상의 치환기로 치환될 수 있는 것이다.
- 제 13 항에 있어서, R이 페닐이고, R1이 t-부틸옥시카르보닐인 방법.
- 제 13 항에 있어서, R2가 페닐 고리의 파라 위치에 치환된 니트로인 방법.
- 제 13 항에 있어서, R3과 R4가 각각 메틸인 방법.
- 제 13 항에 있어서, 추가적으로 설폭소늄 화합물을 유기 용매 내에서 염기와 반응시켜 상기 설퍼 일리드 화합물을 생성시키는 단계를 추가적으로 포함하는 방법.
- 아래의 화학식으로 표현되는 화합물:식 중, R은 알킬, 치환된 알킬, 아릴 및 치환된 아릴로 구성된 군에서 선택되고, R1은 아미노기를 위한 보호기이며, R3과 R4는 알킬, 치환된 알킬 및 아릴로 구성된 군에서 선택되는 것인데,상기 치환된 알킬은 할로, 트리플루오로메틸, 트리플루오로메톡시, 히드록시, 알콕시, 시클로알킬옥시, 헤테로시클로옥시, 옥소, 알칸노일, 아릴, 아릴옥시, 아르알킬, 알카노일옥시, 아미노, 알킬아미노, 아릴아미노, 아르알킬아미노, 시클로알킬아미노, 헤테로시클로아미노 및 디치환 아미노로 구성된 군에서 선택되는 1 내지 4개의 치환기로 치환된 알킬기를 나타내는 것이고,상기 치환된 아릴은 알킬, 치환된 알킬, 할로, 트리플루오로메틸, 트리플루오로메톡시, 히드록시, 알콕시, 시클로알킬옥시, 헤테로시클로옥시, 알카노일, 알카노일옥시, 아미노, 알킬아미노, 디알킬아미노, 아르알킬아미노, 시클로알킬아미노, 헤테로시클로아미노, 알카노일아미노, 티올, 알킬티오, 시클로알킬티오, 헤테로시클로티오, 우레이도(ureido), 니트로, 시아노, 카르복시, 카르복시알킬, 카바밀, 알콕시카르보닐, 알킬티오노, 아릴티오노, 알킬설포닐, 설폰아미도 및 아릴옥시로 구성된 군에서 선택되는 1 내지 4개의 치환기로 치환된 아릴기를 나타내는 것으로서, 상기 치환된 아릴기의 치환기는 추가로 할로, 히드록시, 알킬, 알콕시, 아릴, 치환된 알킬, 치환된 아릴 및 아르알킬로 구성된 군에서 선택되는 1개 이상의 치환기로 치환될 수 있는 것이다.
- 제 18 항에 있어서, R이 페닐이고, R1이 t-부틸옥시카르보닐인 화합물.
- 제 18 항에 있어서, R3과 R4가 각각 메틸인 화합물.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22571100P | 2000-08-16 | 2000-08-16 | |
US60/225,711 | 2000-08-16 | ||
PCT/US2001/023114 WO2002014256A1 (en) | 2000-08-16 | 2001-07-20 | A PROCESS FOR THE PREPARATION OF α' CHLOROKETONES |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030090596A KR20030090596A (ko) | 2003-11-28 |
KR100768961B1 true KR100768961B1 (ko) | 2007-10-23 |
Family
ID=22845919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020037002215A KR100768961B1 (ko) | 2000-08-16 | 2001-07-20 | α' 클로로케톤의 제조방법 |
Country Status (22)
Country | Link |
---|---|
US (1) | US6399793B1 (ko) |
EP (1) | EP1309535B1 (ko) |
JP (1) | JP4889909B2 (ko) |
KR (1) | KR100768961B1 (ko) |
CN (1) | CN1264792C (ko) |
AT (1) | ATE390400T1 (ko) |
AU (2) | AU8294401A (ko) |
BR (1) | BR0112820A (ko) |
CA (1) | CA2419751A1 (ko) |
CY (1) | CY1108120T1 (ko) |
CZ (1) | CZ301422B6 (ko) |
DE (1) | DE60133395T2 (ko) |
DK (1) | DK1309535T3 (ko) |
ES (1) | ES2302743T3 (ko) |
HK (1) | HK1052001A1 (ko) |
HU (1) | HU229795B1 (ko) |
IL (1) | IL153830A0 (ko) |
MX (1) | MXPA03001314A (ko) |
PL (1) | PL366108A1 (ko) |
PT (1) | PT1309535E (ko) |
TW (1) | TWI233925B (ko) |
WO (1) | WO2002014256A1 (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4143787B2 (ja) * | 1999-07-28 | 2008-09-03 | 味の素株式会社 | α−アミノハロメチルケトン誘導体の製造方法 |
US6924397B2 (en) * | 2003-10-22 | 2005-08-02 | Bristol-Myers Squibb Company | Process for the preparation of α-chloroketones from alkyl esters |
FR2921060B1 (fr) * | 2007-09-14 | 2012-06-15 | Novexel | Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires |
US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
ES2516916T3 (es) | 2010-01-28 | 2014-10-31 | Mapi Pharma Limited | Procedimiento para la preparación de darunavir e intermedios de darunavir |
EP3300799A1 (de) | 2016-09-30 | 2018-04-04 | Evonik Degussa GmbH | Verfahren und katalysator zur herstellung von 1,4-butandiol |
US11401224B2 (en) | 2018-02-14 | 2022-08-02 | Evonik Operations Gmbh | Method for the preparation of C3—C12-alcohols by catalytic hydrogenation of the corresponding aldehydes |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0774453A1 (en) | 1995-11-17 | 1997-05-21 | Ajinomoto Co., Inc. | Process for producing 3-amino-2-oxo-1-halogenopropane derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849911A (en) | 1996-04-22 | 1998-12-15 | Novartis Finance Corporation | Antivirally active heterocyclic azahexane derivatives |
-
2001
- 2001-07-18 US US09/908,516 patent/US6399793B1/en not_active Expired - Lifetime
- 2001-07-20 PL PL01366108A patent/PL366108A1/xx not_active Application Discontinuation
- 2001-07-20 CN CNB018141641A patent/CN1264792C/zh not_active Expired - Lifetime
- 2001-07-20 CZ CZ20030419A patent/CZ301422B6/cs not_active IP Right Cessation
- 2001-07-20 AU AU8294401A patent/AU8294401A/xx active Pending
- 2001-07-20 DE DE60133395T patent/DE60133395T2/de not_active Expired - Lifetime
- 2001-07-20 PT PT01961698T patent/PT1309535E/pt unknown
- 2001-07-20 KR KR1020037002215A patent/KR100768961B1/ko active IP Right Grant
- 2001-07-20 AU AU2001282944A patent/AU2001282944B2/en not_active Expired
- 2001-07-20 JP JP2002519403A patent/JP4889909B2/ja not_active Expired - Lifetime
- 2001-07-20 HU HU0302344A patent/HU229795B1/hu unknown
- 2001-07-20 EP EP01961698A patent/EP1309535B1/en not_active Expired - Lifetime
- 2001-07-20 ES ES01961698T patent/ES2302743T3/es not_active Expired - Lifetime
- 2001-07-20 CA CA002419751A patent/CA2419751A1/en not_active Abandoned
- 2001-07-20 AT AT01961698T patent/ATE390400T1/de active
- 2001-07-20 WO PCT/US2001/023114 patent/WO2002014256A1/en active IP Right Grant
- 2001-07-20 DK DK01961698T patent/DK1309535T3/da active
- 2001-07-20 MX MXPA03001314A patent/MXPA03001314A/es active IP Right Grant
- 2001-07-20 IL IL15383001A patent/IL153830A0/xx active IP Right Grant
- 2001-07-20 BR BR0112820-5A patent/BR0112820A/pt not_active Application Discontinuation
- 2001-08-10 TW TW090119584A patent/TWI233925B/zh not_active IP Right Cessation
-
2003
- 2003-06-17 HK HK03104335A patent/HK1052001A1/xx not_active IP Right Cessation
-
2008
- 2008-06-05 CY CY20081100592T patent/CY1108120T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0774453A1 (en) | 1995-11-17 | 1997-05-21 | Ajinomoto Co., Inc. | Process for producing 3-amino-2-oxo-1-halogenopropane derivatives |
Non-Patent Citations (1)
Title |
---|
J.Heterocyclic Chem.,Vol.25(3),p943 |
Also Published As
Publication number | Publication date |
---|---|
CZ301422B6 (cs) | 2010-02-24 |
CN1264792C (zh) | 2006-07-19 |
BR0112820A (pt) | 2005-06-07 |
PT1309535E (pt) | 2008-06-09 |
EP1309535A1 (en) | 2003-05-14 |
AU8294401A (en) | 2002-02-25 |
CN1466561A (zh) | 2004-01-07 |
US6399793B1 (en) | 2002-06-04 |
TWI233925B (en) | 2005-06-11 |
WO2002014256A1 (en) | 2002-02-21 |
HK1052001A1 (en) | 2003-08-29 |
PL366108A1 (en) | 2005-01-24 |
HUP0302344A2 (hu) | 2003-10-28 |
JP2004508302A (ja) | 2004-03-18 |
US20020026079A1 (en) | 2002-02-28 |
EP1309535A4 (en) | 2005-08-03 |
IL153830A0 (en) | 2003-07-31 |
CZ2003419A3 (cs) | 2003-08-13 |
DE60133395T2 (de) | 2009-04-23 |
EP1309535B1 (en) | 2008-03-26 |
ES2302743T3 (es) | 2008-08-01 |
CA2419751A1 (en) | 2002-02-21 |
HUP0302344A3 (en) | 2007-03-28 |
AU2001282944B2 (en) | 2005-08-04 |
HU229795B1 (en) | 2014-07-28 |
ATE390400T1 (de) | 2008-04-15 |
MXPA03001314A (es) | 2004-04-05 |
DK1309535T3 (da) | 2008-07-14 |
JP4889909B2 (ja) | 2012-03-07 |
KR20030090596A (ko) | 2003-11-28 |
CY1108120T1 (el) | 2014-02-12 |
DE60133395D1 (de) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Evans et al. | A stereocontrolled synthesis of hydroxyethylene dipeptide isosteres using novel, chiral aminoalkyl epoxides and. gamma.-(aminoalkyl)-. gamma.-lactones | |
US4716235A (en) | Process for preparing N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline | |
JP3665343B2 (ja) | α−ハロケトン、α−ハロヒドリン及びエポキシドの製造法 | |
KR100768961B1 (ko) | α' 클로로케톤의 제조방법 | |
TW201725191A (zh) | 新穎方法及中間物 | |
US7335792B2 (en) | Process for synthesizing aspartic and glutamic acid derivatives especially useful as intermediates in the manufacture of a caspase inhibitor | |
BRPI0307293B1 (pt) | Processo para preparação de perindopril de alta pureza | |
US8624024B2 (en) | Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol | |
AU2001282944A1 (en) | A process for the preparation of alpha' chloroketones | |
US6639094B2 (en) | Process for producing α-aminoketone derivatives | |
US6500985B2 (en) | Process for producing alpha-aminoketones | |
JP4197741B2 (ja) | 3―ピロリン―2―カルボン酸誘導体の製法 | |
Valls et al. | Synthesis of β-chloro α-amino acids:(2S, 3R)-and (2S, 3S)-3-chloroleucine | |
US9732049B2 (en) | Process for preparing 2,4-diamino-3-hydroxybutyric acid derivatives | |
US5646287A (en) | Reagents for enantioselective acylation and related reactions | |
JP3699769B2 (ja) | ペプチド型化合物 | |
WO2001060795A1 (fr) | Procedes pour preparer des derives d'aminoacides a activite optique | |
US20030158436A1 (en) | Synthesis of alpha--amino-alpha, alpha'- dihaloketones and process for the preparation of beta--amino acid derivatives by the use of the same | |
CA2347246A1 (en) | Stereoselective process for producing cryptophycins | |
CZ21099A3 (cs) | Příprava derivátů 3-pyrrolin-2-karboxylové kyseliny | |
JPH01121297A (ja) | N−置換−アミノ酸誘導体の製造方法 | |
KR20020072302A (ko) | 1,3,4-옥사디아졸 유도체 및 그 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120924 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20130926 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140923 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150918 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160921 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170919 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180918 Year of fee payment: 12 |